Skip to main content

PREEMPT HF

03579641

PREEMPT HF

Associated Conditions

Heart Failure

Principal Investigator

Sponsor

Boston Scientific

The goal of the PREEMPT-HF study is to collect device and clinical event data to evaluate extended applications of the HeartLogic Heart Failure Diagnostic (HeartLogic) in a broad spectrum of heart failure (HF) patients with an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D).

This study is currently enrolling.